Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Paragavialidium hainanense

ABSTRACT: Paragavialidium hainanense Genome sequencing and assembly

PROVIDER: PRJNA977109 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25016521_1.fastq.gz	Fastqsanger.gz
	SRR25016521_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Dendrobium hainanense

Project description:Dendrobium hainanense chloroplast genome sequencing and assembly

| PRJNA810278 | ENA

Dendrobium hainanense

Project description:Dendrobium hainanense overview

| PRJNA898029 | ENA

Paragavialidium hainanense

Project description:Paragavialidium hainanense overview

| PRJNA977372 | ENA

Mycobacterium hainanense strain:HNNTM2301

Project description:Mycobacterium hainanense strain:HNNTM2301 Genome sequencing

| PRJNA1151975 | ENA

Rhododendron hainanense

Project description:Rhododendron hainanense Transcriptome or Gene expression

| PRJNA389341 | ENA

Macrobrachium hainanense isolate:CB-2024A

Project description:Macrobrachium hainanense isolate:CB-2024A Genome sequencing

| PRJNA1172361 | ENA

Rhododendron hainanense SWATH-MS

Project description:Heat stress is the primary obstacle for landscape application of azalea in hot-summer areas. Heat acclimation can confer acquired thermotolerance to R. hainanense even after a long recovery. The mechanisms and key factors involved in the heat acclimation memory were investigated.

2020-04-02 | PXD017005 | Pride

Martinezella hainanensis strain:ccbau 57015

Project description:Rhizobium hainanense CCBAU 57015 genome sequencing

| PRJNA303278 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc